GlassScriptPhysician profile
William B Trattler
NPI 1093730996
$579,293.89
in general payments reported to CMS, 2019-2025
59 companies · $130K in 2025
The $130K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $128K · 2020: $46K · 2021: $72K · 2022: $59K · 2023: $58K · 2024: $86K · 2025: $130K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $153K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $63K · Food and Beverage: $28K · Travel and Lodging: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Honoraria: $6,326 · Entertainment: $215 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $152,852.25 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $62,600.00 |
| Food and Beverage | $27,981.80 |
| Travel and Lodging | $12,268.09 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,950.00 |
| Honoraria | $6,325.59 |
| Entertainment | $214.84 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $148,280.78 | 2022-2025 | Miebo, Xiidra, Stellaris Elite |
| Johnson & Johnson Surgical Vision, INC. | $46,240.78 | 2019-2025 | Tecnis Iol, Baerveldt Glaucoma Implant (250), Compact Intuitiv |
| Alcon Vision LLC | $45,874.01 | 2019-2025 | Tryptyr, Acrysof Iq Vivity, Acrysof Iq Panoptix Uv Iol |
| Lensar, INC. | $44,447.88 | 2019-2025 | Lensar Laser System |
| Kala Pharmaceuticals, INC. | $40,098.20 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $35,627.62 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $26,244.79 | 2019-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $19,167.90 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $17,150.26 | 2019-2023 | |
| Sight Sciences, INC. | $17,049.64 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Carl Zeiss Meditec, INC. | $15,832.03 | 2019-2024 | Veracity Surgical, Quatera 700, Visumax |
| Beaver-Visitec International, INC. | $15,527.37 | 2019-2025 | |
| Shire North American Group INC | $13,326.04 | 2019 | |
| Abbvie INC. | $13,009.16 | 2022-2025 | Vuity, Lumigan, Durysta |
| Dompe US, INC. | $11,295.15 | 2019-2024 | Oxervate |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $10,700.68 | 2019-2022 | |
| Biotissue Holdings INC. | $9,755.17 | 2019-2024 | |
| Glaukos Corporation | $7,633.33 | 2020-2025 | Kxl System (Not Refurbished), Kxl System, Photrexa Viscous and Photrexa |
| Alcon Research LLC | $6,751.00 | 2019-2024 | |
| Omeros Corporation | $4,684.56 | 2019-2021 | |
| Oculus, INC. | $4,500.00 | 2024-2025 | Pentacam Oct, Pentacam, Pentacam Axl Wave |
| Mallinckrodt Hospital Products INC. | $3,744.98 | 2020-2025 | Acthar |
| Thea Pharma INC. | $2,985.76 | 2022-2025 | Iyuzeh |
| Harrow Eye, LLC | $2,894.76 | 2024-2025 | Vevye, Vigamox, Triesence |
| Eyevance Pharmaceuticals LLC | $2,330.96 | 2019-2022 | |
| Horizon Therapeutics Plc | $2,060.29 | 2022-2023 | Tepezza |
| Eyepoint US, INC. | $1,887.12 | 2019 | |
| Oyster Point Pharma, INC. | $1,571.23 | 2022-2025 | Ryzumvi, Tyrvaya |
| New World Medical,INC. | $1,315.59 | 2022-2023 | |
| Nordic Pharma, INC. | $1,050.00 | 2025 | Lacrifill |
| Aerie Pharmaceuticals, INC. | $702.49 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $687.82 | 2019-2024 | Tecnis Simplicity, Mentor Siltex Round Spectrum |
| Carl Zeiss Meditec USA, INC. | $521.33 | 2022-2025 | Cirrus Hd-Oct, Quatera 700 |
| Astellas Pharma US INC | $502.00 | 2024-2025 | Izervay |
| Regeneron Healthcare Solutions, INC. | $476.21 | 2019-2025 | Eylea Hd, Eylea |
| Rayner Intraocular Lenses Limited | $426.86 | 2022-2025 | Rayone Emv, Rayone Aspheric, Rayone Spheric |
| Amgen INC. | $386.31 | 2024-2025 | Tepezza |
| Rxsight INC | $383.26 | 2021-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Apellis Pharmaceuticals, INC. | $337.51 | 2022-2025 | Syfovre |
| Mallinckrodt Enterprises LLC | $292.06 | 2019 | |
| Optos, INC. | $214.84 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec Cataract Technology INC. | $187.51 | 2019-2021 | |
| Coopervision INC. | $169.88 | 2023-2025 | Myday Contact Lens, Onefit Contact Lens |
| Ani Pharmaceuticals, INC. | $156.77 | 2023-2025 | Purified Cortrophin Gel, Iluvien |
| Ocular Therapeutix, INC. | $136.29 | 2019-2025 | Dextenza |
| Merz Pharmaceuticals, LLC | $101.86 | 2025 | Xeomin |
| Genentech USA, INC. | $85.02 | 2023-2025 | Vabysmo |
| Ortho-Clinical Diagnostics, INC. | $74.30 | 2024 | Inflammadry |
| Katalyst Surgical, LLC | $72.47 | 2023 | |
| Staar Surgical Company | $67.37 | 2019 | |
| Quidel Corporation | $46.51 | 2022 | |
| Coherus Oncology, INC. | $43.64 | 2023 | |
| Alimera Sciences, INC. | $35.57 | 2022 | |
| Immunocore Limited | $30.33 | 2023 | Kimmtrak |
| Haag-Streit USA, INC. | $27.72 | 2022 | |
| Dutch Ophthalmic, USA | $26.44 | 2022 | |
| Halozyme INC | $25.62 | 2020 | |
| Akorn, INC. | $19.46 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,250.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Trattler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.